<code id='90370EEE28'></code><style id='90370EEE28'></style>
    • <acronym id='90370EEE28'></acronym>
      <center id='90370EEE28'><center id='90370EEE28'><tfoot id='90370EEE28'></tfoot></center><abbr id='90370EEE28'><dir id='90370EEE28'><tfoot id='90370EEE28'></tfoot><noframes id='90370EEE28'>

    • <optgroup id='90370EEE28'><strike id='90370EEE28'><sup id='90370EEE28'></sup></strike><code id='90370EEE28'></code></optgroup>
        1. <b id='90370EEE28'><label id='90370EEE28'><select id='90370EEE28'><dt id='90370EEE28'><span id='90370EEE28'></span></dt></select></label></b><u id='90370EEE28'></u>
          <i id='90370EEE28'><strike id='90370EEE28'><tt id='90370EEE28'><pre id='90370EEE28'></pre></tt></strike></i>

          knowledge

          knowledge

          author:comprehensive    Page View:28
          U.S. Sen. John Thune (R-SD) arrives for a Senate Republican meeting at the U.S. Capitol on February 08, 2024 in Washington, DC.
          Senate Minority Whip John Thune is one member of a bipartisan group working to develop Medicare physician payment reforms. Kevin Dietsch/Getty Images

          WASHINGTON — A bipartisan group of senators is starting work on legislation to reform how Medicare pays physicians, they will announce Friday.

          Senate Minority Whip John Thune (R-S.D.) and Sens. Marsha Blackburn (R-Tenn.), John Barrasso (R-Wyo.), Debbie Stabenow (D-Mich.), Mark Warner (D-Va.), and Catherine Cortez Masto (D-Nev.) announced their intent to develop long-term fixes to issues with Medicare’s physician payment structure and to update the Medicare Access and CHIP Reauthorization Act.

          advertisement

          “Further action is needed to address reimbursement challenges and shift toward a system that aligns payment incentives with patient outcomes,” they said in a written statement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more
          Why the drug industry's warnings on the IRA's impact fall short
          Why the drug industry's warnings on the IRA's impact fall short

          AdobeEversinceMedicarewasgivenpowertonegotiatepricesforcertainmedicines,thepharmaceuticalindustryhas

          read more
          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more

          PBMs drew scrutiny in House hearing — and so did pharma

          Rep.JamesComer,chairoftheHouseOversightCommitteeKevinDietsch/GettyImagesWASHINGTON—Congresswantstore